Skip to main content

Novasep in double exit

French-based CDMO Novasep has announced two sales. Henagen, its Belgium-based viral vectors operation, has been sold to Thermo Fisher Scientific for about €725 million, while, in a much smaller deal, it also intends to sell its chromatography equipment division to Sartorius Stedim Biotech.

Thermo Fisher buys GSK Irish site

Thermo Fisher Scientific, owner of Patheon, has agreed to acquire a drug substance manufacturing site in Cork, Ireland, from GlaxoSmithKline (GSK) for about €90 million.
Subscribe to Thermo Fisher

 

SC newsletter banner